Iovance Biotherapeutics, Inc. (IOVA)
14.62
-0.24
(-1.62%)
USD |
NASDAQ |
Oct 21, 16:00
14.51
-0.11
(-0.75%)
After-Hours: 20:00
Iovance Biotherapeutics Net Income (Annual) : -390.98M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -390.98M |
| December 31, 2024 | -372.18M |
| December 31, 2023 | -444.04M |
| December 31, 2022 | -395.89M |
| December 31, 2021 | -342.25M |
| December 31, 2020 | -259.58M |
| December 31, 2019 | -197.56M |
| December 31, 2018 | -123.58M |
| December 31, 2017 | -92.06M |
| Date | Value |
|---|---|
| December 31, 2016 | -52.89M |
| December 31, 2015 | -27.66M |
| December 31, 2014 | -12.03M |
| December 31, 2013 | -25.38M |
| December 31, 2012 | -3.308M |
| December 31, 2011 | -25.69M |
| December 31, 2010 | -1.608M |
| December 31, 2009 | -0.0158M |
| December 31, 2008 | -0.0571M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Halozyme Therapeutics, Inc. | 316.89M |
| AVITA Medical, Inc. | -48.59M |
| CareDx, Inc. | -21.35M |
| Amgen, Inc. | 7.711B |
| Xencor, Inc. | -92.14M |